What is the evidence that ecstasy (MDMA) can cause Parkinson's disease?

被引:24
作者
Kish, SJ [1 ]
机构
[1] Ctr Addict & Mental Hlth, Human Neurochem Pathol Lab, Toronto, ON, Canada
关键词
D O I
10.1002/mds.10643
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1219 / 1223
页数:5
相关论文
共 27 条
[1]  
BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911
[2]  
Buchert R, 2003, J NUCL MED, V44, P375
[3]  
COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338
[4]  
Kalant H, 2001, CAN MED ASSOC J, V165, P917
[5]   The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens [J].
Kankaanpää, A ;
Meririnne, E ;
Lillsunde, P ;
Seppälä, T .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (04) :1003-1009
[6]   Expedited publication - Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user [J].
Kish, SJ ;
Furukawa, Y ;
Ang, L ;
Vorce, SP ;
Kalasinsky, KS .
NEUROLOGY, 2000, 55 (02) :294-296
[7]   How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? [J].
Kish, SJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) :845-855
[8]   MDMA and parkinsonism [J].
Kuniyoshi, SM ;
Jankovic, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) :96-97
[9]   Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans [J].
Liechti, ME ;
Vollenweider, FX .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2000, 10 (04) :289-295
[10]   Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans [J].
Liechti, ME ;
Saur, MR ;
Gamma, A ;
Hell, D ;
Vollenweider, FX .
NEUROPSYCHOPHARMACOLOGY, 2000, 23 (04) :396-404